SCA Pharmaceuticals Appoints Joe Akers as Chief Operating Officer
SCA Pharmaceuticals continues its aggressive expansion and implementation of growth strategies, and in doing so, has appointed Joe Akers as Chief Operating Officer.
Details
The indirect costs of risk management for hospital insourcing
This post is our third in a series of blogs looking at how hospitals make the difficult decision to compound their own drugs versus selecting an outsourcing partner. The decision involves a great deal more than a clean room and a vial of medication. A wide range of indirect costs are specifically related to risk…
Details
SCA Pharmaceuticals Appoints Chief Commercial Officer
WINDSOR, CONN. (Jan. 28, 2021)– SCA Pharmaceuticals, LLC, announced details last week of their acquisition by The Vistria Group and Excellere. Continuing their strategic growth initiatives, SCA Pharma is announcing the appointment of Mr. Scott Luce as Chief Commercial Officer. Mr. Luce will provide leadership and oversight of commercial operations as SCA Pharma continues to…
Details
The Vistria Group and Excellere Capital Management Invest in SCA Pharmaceuticals
WINDSOR, CONN. (Jan. 21, 2021) – SCA Pharmaceuticals, LLC (“SCA Pharma”), has entered into a definitive membership interest purchase agreement with The Vistria Group (“Vistria”) and Excellere Partners (“Excellere”). The Vistria Group and Excellere Partners have purchased all of the issued and outstanding equity interests of SCA Pharma. The terms of the transaction were not…
Details
Thinking of compounding in-house? Don’t forget to calculate these three “hidden” costs.
SCA Pharma is taking a look at how hospitals choose to supply their compounded drug products. Many choose to produce what they need internally – called insourcing – while others use a provider like us – outsourcing. This second blog post in a 3-part series examines the unseen costs of insourcing vs. outsourcing with a…
Details
SCA Pharma unveils new virtual tour at HCP fall conference
SCA Pharma just wrapped up the Health Connect Partners (HCP) Hospital Pharmacy fall virtual conference, where we shared a new virtual tour of the SCA Pharma facilities. The tour highlights the steps throughout the product journey, from receiving materials to compounding to packing and shipping the finished products to hospital pharmacies, and gives viewers an…
Details
Insourcing versus Outsourcing – the indirect costs of insourcing
Hospitals often choose to insource drug compounding in order to save money on Pharmacy costs. The decision to insource is typically based on a number of factors including cost of raw materials and qualified personnel needed to compound the product. We believe that hospitals often fail to include many indirect variables, resulting in under-estimation of…
Details
SCA Pharma champions safe pain control for patients
October is National Medicine Abuse Awareness Month, an annual effort by the Community Anti-Drug Coalitions of America to raise awareness of the dangers of prescription and over-the-counter medicine abuse. And SCA Pharma is partnering with hospital pharmacies to better control pain in patients safely. According to the Journal of the American Medical Association (JAMA), the…
Details
SCA Pharma to offer virtual tours at Health Connect Partners fall conference
SCA Pharma will exhibit at Health Connect Partners 2020 fall virtual conference.
Details
SCA Pharma touts Kit Check partnership during HCP Roundtable
HCP Roundtable discussion gives SCA Pharma the opportunity to share benefits of partnership with Kit Check.
Details